GJB2
protein-codinggap junction protein beta 2, the group of Gap junction proteins
Gene summary
This gene encodes a member of the gap junction protein family (gap junction beta 2) but is more commonly known as connexin 26. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. Connexins form hexameric channels in the plasma membrane which regulate passage of ions and small molecules between the cell and its environment or, when joined with another cell, form a dodecameric intercellular gap junction channel. The connexin proteins are grouped into alpha, beta, and gamma subfamilies. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Mar 2026]
- DFNB1
- DFNA3
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~5.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0011245
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0019497
Submitter: ClinGen
GJB2 was first reported in relation to autosomal recessive nonsyndromic hearing loss (DFNB1) in 1997 (Kelsell et al., PMID: 9139825). 8 variants (missense, nonsense, frameshift, and canonical splice site) that have been reported in 6 probands in 4 publications (PMIDs: 9139825, 9482292, 9529365, 16380907) are included in this curation. Variants in GJB2 are found in up to 50% of patients with autosomal recessive nonsyndromic hearing loss (PMID: 16380907). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is known to be loss of function. This gene-disease relationship is also supported by experimental evidence. Expression studies in the human cochlea, mouse models with wildtype GJB2 rescuing hearing loss and abnormal inner ear morphology, and in vitro dye transfer and electrical coupling assays demonstrating significant differences between functionally impaired variants and wildtype GJB2 all support this gene-disease relationship (PMIDs: 9507396, 12176036, 15241677, 21876744, 25801282). In summary, there is definitive evidence supporting the relationship between GJB2 and autosomal recessive nonsyndromic hearing loss. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Hearing Loss Gene Curation Expert Panel on March 2, 2017. As of September 24, 2024, this record underwent administrative updates to update the SOP version (SOP Version 10.1). No new evidence has been reviewed or added.
Inheritance Pattern: AD
Disease ID:MONDO:0007866
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0019588
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007852
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0007422
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0007850
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0009076
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0007866
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009076
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0011103
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009076
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Inheritance Pattern: AD
Disease ID:MONDO:0007422
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0007852
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0005365
Submitter: ClinGen
GJB2 was first reported in relation to autosomal dominant hearing loss with or without skin findings in 1998 (Richard et al., 9856479). At least 30 missense variants have been reported in humans. Association is seen in at least 11 probands in 11 publications (PMIDs: 11354642, 11912510, 15337980, 20937258, 21868108, 9856479, 9620796, 10369869, 10807696, 16226720, 28102197). Variants in this gene segregated with disease in 49 additional family members. Much more evidence is available in the literature, but the maximum score for genetic evidence and/or experimental evidence (12 pts.) has been reached. This gene-disease relationship is supported by animal models, expression studies, in vitro functional assays, and biochemical functional studies, which support a dominant-negative mechanism of disease. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism and inheritance pattern for AD nonsyndromic hearing loss, AD keratitis ichthyosis deafness (KID) and AD palmoplantar keratoderma (PPK) with deafness. It is possible that these phenotypes exist on a spectrum of disease. In summary, GJB2 is definitively associated with autosomal dominant Hearing Loss with or without Skin Findings. This classification was approved by the ClinGen Hearing Loss Working Group on 6/26/2018.
Inheritance Pattern: AD
Disease ID:MONDO:0007850
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0019587
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0011103
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009076
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0007422
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0018781
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0011245
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0007866
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0007852
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007850
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0011103
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Dermatologic; Oncologic; Ophthalmologic
Intervention: Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Oncologic
Rationale: Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; In certain conditions (eg, KID syndrome), infectious and malignant complications may benefit from surveillance leading to microbial prophylaxis and early and aggressive treatment of infections and early detection and treatment of malignancy
Comments: In nonsyndromic deafness, onset of AD disease can be pre or postlingual; In syndromic disease, although skin and other findings may be obvious in some individuals, the syndromic combination of features may not be as readily appreciated as being related to hearing impairment; Digenic inheritance (with GJB3, GJB6) has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to GJB2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004004.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 122 | 1 | 126 | ||
| missense | 46 | 132 | 140 | 15 | 3 | 336 |
| nonsense | 21 | 13 | 1 | 35 | ||
| start loss | 4 | 1 | 5 | |||
| frameshift | 40 | 33 | 1 | 74 | ||
| splice donor/acceptor (+/-2bp) | 5 | 1 | 6 | |||
| Total | 111 | 184 | 146 | 137 | 4 | 582 |
Highest pathogenic variant AF is 0.012041303
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003995.2 | 1 | MANE Select | |
| Ensembl | ENSP00000372299.4 | 1 | MANE Select | |
| Ensembl | ENSP00000372295.1 | 1 | Standard | |
| Ensembl | ENSP00000576289.1 | 1 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| cx30.3 | Danio rerio | Structure: sagitta Quality: decreased width abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Calcium Regulation in the Cardiac Cell
- Vesicle-mediated transport
- Membrane Trafficking
- Transport of connexins along the secretory pathway
- Oligomerization of connexins into connexons
Biological Process
- response to ischemia
- cell-cell signaling
- aging
- sensory perception of sound
- gap junction assembly
Molecular Function
- gap junction channel activity
- identical protein binding
Cellular Component
- endoplasmic reticulum-Golgi intermediate compartment
- cytosol
- plasma membrane
- connexin complex
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000382844
- Coding exons
- 1
- Length
- 5429
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.720 | 161 | 137 | 1.17 | 0.00000846 | 1481 |
| Missense (PolyPhen) | 70 | 67.124 | 1.0428 | 721 | ||
| Synonymous | -0.293 | 64 | 61.1 | 1.05 | 0.00000437 | 446 |
| Loss of Function | -3.82 | 17 | 6.50 | 2.62 | 2.82e-7 | 69 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell.;
- Disease
- DISEASE: Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:10830906, ECO:0000269|PubMed:11313763, ECO:0000269|PubMed:11439000, ECO:0000269|PubMed:12121355, ECO:0000269|PubMed:12239718, ECO:0000269|PubMed:12786758, ECO:0000269|PubMed:14722929, ECO:0000269|PubMed:15592461, ECO:0000269|PubMed:15666300, ECO:0000269|PubMed:15994881, ECO:0000269|PubMed:17660464, ECO:0000269|PubMed:17666888, ECO:0000269|PubMed:19384972, ECO:0000269|PubMed:23680645, ECO:0000269|PubMed:28281779, ECO:0000269|PubMed:9328482, ECO:0000269|PubMed:9336442, ECO:0000269|PubMed:9471561, ECO:0000269|PubMed:9529365}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal dominant, 3A (DFNA3A) [MIM:601544]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:10807696, ECO:0000269|PubMed:11313763, ECO:0000269|PubMed:11439000, ECO:0000269|PubMed:12668604, ECO:0000269|PubMed:12786758, ECO:0000269|PubMed:19384972, ECO:0000269|PubMed:9620796}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Vohwinkel syndrome (VOWNKL) [MIM:124500]: An autosomal dominant disease characterized by hyperkeratosis, constriction on fingers and toes and congenital deafness. {ECO:0000269|PubMed:10369869, ECO:0000269|PubMed:12668604, ECO:0000269|PubMed:15954104, ECO:0000269|PubMed:18688874}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Keratoderma, palmoplantar, with deafness (PPKDFN) [MIM:148350]: An autosomal dominant disorder characterized by the association of palmoplantar hyperkeratosis with progressive, bilateral, high-frequency, sensorineural deafness. {ECO:0000269|PubMed:10633135, ECO:0000269|PubMed:10757647, ECO:0000269|PubMed:12372058, ECO:0000269|PubMed:12668604, ECO:0000269|PubMed:15996214, ECO:0000269|PubMed:17993581, ECO:0000269|PubMed:9856479}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Keratitis-ichthyosis-deafness syndrome (KID syndrome) [MIM:148210]: An autosomal dominant form of ectodermal dysplasia. Ectodermal dysplasia defines a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. Keratitis-ichthyosis-deafness syndrome is characterized by the association of hyperkeratotic skin lesions with vascularizing keratitis and profound sensorineural hearing loss. Clinical features include deafness, ichthyosis, photophobia, absent or decreased eyebrows, sparse or absent scalp hair, decreased sweating and dysplastic finger and toenails. {ECO:0000269|PubMed:11912510, ECO:0000269|PubMed:12548749, ECO:0000269|PubMed:12752120}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bart-Pumphrey syndrome (BPS) [MIM:149200]: An autosomal dominant disorder characterized by sensorineural hearing loss, palmoplantar keratoderma, knuckle pads, and leukonychia, It shows considerable phenotypic variability. {ECO:0000269|PubMed:15482471, ECO:0000269|PubMed:15952212}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ichthyosis hystrix-like with deafness syndrome (HID syndrome) [MIM:602540]: An autosomal dominant keratinizing disorder characterized by sensorineural deafness and spiky hyperkeratosis affecting the entire skin. HID syndrome is considered to differ from the similar KID syndrome in the extent and time of occurrence of skin symptoms and the severity of the associated keratitis. {ECO:0000269|PubMed:12072059}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.506
Intolerance Scores
- LoFtool
- 0.163
- RVIS EVS
- 0.66
- RVIS percentile EVS
- 84.55
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.801
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |